Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus fermentum CECT5716

Safety profile

3 studies reporting safety data

Across 3 clinical studies, no specific adverse events were statistically associated with Lactobacillus fermentum CECT5716. The probiotic was described as well tolerated in all three studies, with one study reporting similar rates of diarrhea between groups (7.84% vs 8.0%). No serious adverse events were reported, and no significant differences in safety markers were observed.

Caveats: Limited evidence base (3 studies); absence of reports does not establish safety. Studies may not be powered to detect rare adverse events, and the duration of exposure may be insufficient to capture long-term effects.

Most-studied combinations with Lactobacillus fermentum CECT5716

most supplement research is combination research
Also studied with:Lactobacillus reuteri NCIMB 30242 (2)
  • Mum

    By BioGaia

    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $28.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
Back to top